Publications
Value in Health · May 1, 2019
PCN310 REAL WORLD SURVIVAL OUTCOMES WITH MODIFIED DOSE SCHEDULE OF BORTEZOMIB, MELPHALAN AND PREDNISONE IN PREVIOUSLY UNTREATED TRANSPLANT INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA: A POPULATION BASED OBSERVATIONAL STUDY
Frida Schain, Nurgul Batyrbekova, Sarah Côté
Multiple Myeloma Research and TreatmentsBone health and treatmentsMultiple Sclerosis Research Studiesmultiple myelomanewly diagnosed multiple myelomatransplant-ineligible patients
More by Nurgul Batyrbekova
- Additional file 1 of Evidence for nephrolithiasis preceding sarcoidosis diagnosis: findings from a Swedish case-control studyFigshare · 2026
- Evidence for nephrolithiasis preceding sarcoidosis diagnosis: findings from a Swedish case-control studyRespiratory Research · 2026
- PO:03:091 Psychiatric morbidity and risk of adverse long-term outcomes in systemic lupus erythematosusLupus Science & Medicine · 2026
- Risk of Transformation to Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients With Myeloproliferative Neoplasms Over Attained Age and Time Since Diagnosis: A Nationwide Cohort StudyEuropean Journal Of Haematology · 2026 · Citations: 1